Ardelyx (ARDX) Equity Ratio (2013 - 2026)
Ardelyx posted quarterly Equity Ratio of 0.29 for Q1 2026, down 17.05% year-on-year from 0.36 in Q1 2025, and down 11.49% on a QoQ basis from 0.33 in Q4 2025.
Ardelyx (ARDX) has 14 years of Equity Ratio data on file, last reported at 0.29 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 17.05% year-over-year to 0.29; the trailing twelve-month figure through Mar 2026 stood at 0.29 (down 17.05% YoY), and the FY2025 full-year result was 0.33, down 16.31% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.29, down from 0.33 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.66 in Q3 2023 and bottomed at 0.29 in Q1 2026.
- The 5-year median for Equity Ratio is 0.43 (2024), against an average of 0.44.
- The widest annual swing landed in 2023, when Equity Ratio jumped 44.69%; it then tumbled 34.86% in 2024.
- A 5-year view of Equity Ratio shows it stood at 0.52 in 2022, then rose by 8.36% to 0.56 in 2023, then dropped by 29.06% to 0.4 in 2024, then declined by 16.31% to 0.33 in 2025, then decreased by 11.49% to 0.29 in 2026.
- The last three Equity Ratio figures came in at 0.29 (Q1 2026), 0.33 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.29 |
| Dec 31, 2025 | 0.33 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.30 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.43 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.66 |
| Jun 30, 2023 | 0.58 |
| Mar 31, 2023 | 0.58 |
| Dec 31, 2022 | 0.52 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.50 |
| Dec 31, 2021 | 0.55 |
| Sep 30, 2021 | 0.48 |
| Jun 30, 2021 | 0.57 |
| Mar 31, 2021 | 0.62 |
| Dec 31, 2020 | 0.63 |
| Sep 30, 2020 | 0.66 |
| Jun 30, 2020 | 0.67 |
| Mar 31, 2020 | 0.71 |
| Dec 31, 2019 | 0.72 |
| Sep 30, 2019 | 0.41 |
| Jun 30, 2019 | 0.50 |
| Mar 31, 2019 | 0.55 |
| Dec 31, 2018 | 0.63 |
| Sep 30, 2018 | 0.68 |
| Jun 30, 2018 | 0.72 |
| Mar 31, 2018 | 0.90 |
| Dec 31, 2017 | 0.88 |
| Sep 30, 2017 | 0.88 |
| Jun 30, 2017 | 0.88 |
| Mar 31, 2017 | 0.89 |
| Dec 31, 2016 | 0.91 |
| Sep 30, 2016 | 0.92 |
| Jun 30, 2016 | 0.90 |
| Mar 31, 2016 | 0.93 |
| Dec 31, 2015 | 0.93 |
| Sep 30, 2015 | 0.91 |
| Jun 30, 2015 | 0.96 |
| Mar 31, 2015 | 0.55 |
| Dec 31, 2014 | 0.54 |
| Sep 30, 2014 | 0.54 |
| Jun 30, 2014 | 0.51 |
| Dec 31, 2013 | -1.48 |